跳转至内容
Merck
CN

573097

WP1066

≥97% (HPLC), STAT3 pathway inhibitor, solid

别名:

STAT3抑制剂III,WP1066

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C17H14BrN3O
化学文摘社编号:
分子量:
356.22
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.77
Assay:
≥97% (HPLC)
Form:
solid
Quality level:
Storage condition:
OK to freeze, protect from light
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

STAT3抑制剂III,WP1066, STAT3 Inhibitor III, WP1066, CAS 857064-38-1, is a cell-permeable AG490 tyrphostin analog that acts as a STAT3 pathway inhibitor. A potent anti-tumor agent.

Quality Level

assay

≥97% (HPLC)

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, protect from light

color

off-white

solubility

DMSO: 10 mg/mL, ethanol: 5 mg/mL

shipped in

ambient

storage temp.

2-8°C

SMILES string

Brc1nc(ccc1)\C=C(\C(=O)N[C@@H](C)c2ccccc2)/C#N

InChI

1S/C17H14BrN3O/c1-12(13-6-3-2-4-7-13)20-17(22)14(11-19)10-15-8-5-9-16(18)21-15/h2-10,12H,1H3,(H,20,22)/b14-10+/t12-/m0/s1

InChI key

VFUAJMPDXIRPKO-LQELWAHVSA-N

General description

一种细胞渗透性AG 490(目录号658401)酪磷蛋白类似物,在体外培养(使用U87-MG和U373-MG进行生存能力试验时,IC50分别为5.6和3.7 µM;在10 µM时对非肿瘤NHA无抑制作用)和小鼠体内培养中,作为有效的STAT3途径抑制剂和比AG 490更有效的抗肿瘤剂抑制恶性胶质瘤生长。显示在小鼠体内能跨越血脑屏障。也可提供InSolution格式(目录号573129)。
一种细胞渗透性AG 490(目录号658401)酪磷蛋白类似物,在体外培养(使用U87-MG和U373-MG进行生存能力试验时,IC50分别为5.6和3.7 µM;在10 µM时对非肿瘤NHA无抑制作用)和小鼠体内培养中,作为有效的STAT3途径抑制剂和比AG 490更有效的抗肿瘤剂抑制恶性胶质瘤生长。显示在小鼠体内能跨越血脑屏障。

Biochem/physiol Actions

主靶
STAT3通路
产物不与ATP竞争。
可逆:否
细胞可渗透性:是
靶标IC50:分别为5.6和3.7 µM,在使用U87-MG和U373-MG的活性试验中,抑制恶性胶质瘤生长

Packaging

用惰性气体包装

Preparation Note

复溶后,等分并冷冻保存(-20°C)。贮备溶液在-20°C下可稳定保存至多6个月。

Other Notes

Iwamaru, A., et al. 2007.Oncogene,26, 2435.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

毒性:刺激性(B)


存储类别

11 - Combustible Solids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容

The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signaling pathway plays an important role in cell proliferation, cell differentiation, cell migration, and cell death. It is the principal signaling mechanism for a variety of cytokines and growth factors. Constitutive activation or dysregulation of JAK/STAT signaling can result in inflammatory disease, erythrocytosis, gigantism, and leukemia.

Pathways and Biomarkers of JAK/STAT Signaling

An Introduction to Inhibitors and Their Biological Applications


Ahmad Sharanek et al.
Cell reports, 36(9), 109647-109647 (2021-09-02)
Brain tumor stem cells (BTSCs) and intratumoral heterogeneity represent major challenges in glioblastoma therapy. Here, we report that the LGALS1 gene, encoding the carbohydrate binding protein, galectin1, is a key regulator of BTSCs and glioblastoma resistance to therapy. Genetic deletion



全球贸易项目编号

货号GTIN
573097-10MG04055977266382